Ensuring Product Quality in Irish Biologic and Biopharmaceutical Logistics through IoT-enabled Cold Chain Monitoring
Authors
Issue Date
Type
Language
Keywords
Alternative Title
Abstract
The fourth industrial revolution along with the advancement in digital technologies have
revolutionized the realm of biologics and biopharmaceutical logistics. This dissertation
embarks on a journey to explore the integration of Internet of things (IoT) enabled technologies
in cold chain monitoring within the Irish biologic and biopharmaceutical logistics sector. The
study focuses on ensuring the quality and safety of temperature-sensitive biologics and
biopharmaceutical products like gene therapies, monoclonal antibodies, vaccines, diagnostic
kits and reagents during storage and transportation till it reaches the end customer.
The study is relevant especially for a country like Ireland renowned for being one of the leading
global hubs in biopharmaceuticals, medical device technology and digital health technology.
The biologic and biopharmaceutical logistics industry of Ireland rely heavily on efficient and
reliable cold chain monitoring to ensure the quality, safety, and efficacy of temperature
sensitive medications, vaccines, and biologics. The ever-increasing demand for vaccines, gene
therapies, monoclonal antibodies, and biomedical products like diagnostic reagents and
medical laboratory supplies post COVID-19 pandemic has made it important to maintain the
optimal storage conditions throughout their transit within the supply chain.
Industry 4.0 technologies like the Internet of things (IoT) can be a game changer in the cold
chain logistics through its capabilities in offering real-time monitoring of temperature and other
environmental factors like humidity, pressure, etc. Through time-monitoring, anomalies in
temperature and other environmental factors can be detected immediately and immediate
measures can be taken to prevent any adversities, thus ensuring the safety and efficacy of the
product.
This research further aims to emphasise the understanding of available IoT technologies having
the potential to transform the biologic and biopharmaceutical cold chain, thus enhancing
product quality and ensuring patient safety.